文献速递神经肿瘤

5因子改良衰弱指数作为立体定向放射外科治疗脑膜瘤预后因素

The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management.
PubMed 文献 · J Neurooncol · 2024-11-14

单中心回顾性队列研究纳入2019至2023年94例接受立体定向放射外科(SRS)治疗的脑膜瘤患者,按5因子改良衰弱指数(mFI-5)分为衰弱前组(0-1分)和衰弱组(2-5分)。衰弱与总生存(OS)接近显著相关(HR 3.66,95%CI 0.49-26.8,p=0.05),与无进展生存(PFS)显著相关(HR 2.95,95%CI 1.12-7.81,p=0.02)。作者结论认为mFI-5评估的衰弱未独立预测OS,但预测了接受SRS脑膜瘤患者的PFS。

要点

  • 衰弱组(mFI-5 2-5分)3年PFS为49.2%,衰弱前组(0-1分)为90.5%,PFS差异显著(HR 2.95,95%CI 1.12-7.81,p=0.02)。
  • 衰弱组3年OS为36.6%,衰弱前组为75.4%,OS关联接近显著(HR 3.66,95%CI 0.49-26.8,p=0.05)。
  • 单变量回归显示衰弱、既往手术切除和累积肿瘤体积预测PFS。

核心结论

  • mFI-5评估的衰弱未独立预测接受SRS脑膜瘤患者的总生存,但预测了无进展生存。

研究设计与样本

  • 单中心、回顾性队列研究,纳入2019至2023年接受SRS治疗的脑膜瘤患者94例。
  • 按mFI-5评分将患者分为衰弱前组(0-1分)和衰弱组(2-5分)。
  • 采用Kaplan-Meier分析评估总生存、无进展生存、局部控制和远处控制,采用Cox比例风险回归分析因素与OS/PFS的关联。

主要发现

  • 衰弱与OS接近显著相关(HR 3.66,95%CI 0.49-26.8,p=0.05),3年OS率衰弱前组75.4% vs 衰弱组36.6%。
  • 衰弱与PFS显著相关(HR 2.95,95%CI 1.12-7.81,p=0.02),3年PFS率衰弱前组90.5% vs 衰弱组49.2%。
  • 单变量回归分析显示衰弱、既往手术切除和累积肿瘤体积预测PFS。

关键数值与推荐

  • mFI-5评分0-1分为衰弱前组,2-5分为衰弱组。
  • 3年OS率:衰弱前组75.4%,衰弱组36.6%。
  • 3年PFS率:衰弱前组90.5%,衰弱组49.2%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Meningiomas are the most frequent primary intracranial malignancy. While surgical resection can confer long term tumor control, stereotactic radiosurgery (SRS) is often used for small, asymptomatic tumors in the adjuvant setting. Frailty has been associated with increased rates of peri-operative morbidity but has yet to be defined in the setting of SRS for meningiomas. We therefore sought to examine the relationship between frailty and clinical/radiographic outcomes of patients with meningiomas who have undergone SRS. METHODS: A single-center, retrospective cohort study classified patients by their 5-factor modified frailty index (mFI-5) score into pre-frail (0-1) and frail (2-5) at the time of SRS treatment. Evaluations of overall survival (OS), progression free survival (PFS), local control (LC), and distant control (DC) were performed using Kaplan-Meier analysis. Cox proportional hazards regression analysis was used to further define factors associated with OS/PFS. RESULTS: 94 patients met inclusion criteria and underwent SRS for meningioma treatment from 2019 to 2023. Analyses compared prefrail (0-1) and frail (2-5) individuals. Kaplan-Meier analysis demonstrated a near significant association between frailty and OS (HR 3.66, 95% CI 0.49-26.8 p = 0.05) with 3-year OS rates of 75.4% in the pre-frail versus 36.6% in the frail group. However, a significant relationship was demonstrated between frailty and PFS (HR: 2.95 95% CI 1.12-7.81, p = 0.02) with 3-year PFS rates of 90.5% in the pre-frail group versus 49.2% in the frail group. Univariable regression analysis demonstrated that frailty, prior surgical excision, and cumulative tumor volume predicted PFS. CONCLUSION: Frailty, as assessed by the mFI-5, did not independently predict OS but did predict PFS in individuals with meningioma undergoing SRS.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Herr S, Kite T, Vyas P, et al. The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management. J Neurooncol. 2024. PMID: 39543050. doi:10.1007/s11060-024-04873-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。